Clinical Trial Update: An Italian Multicenter Retrospective Observational Study to Assess Effectiveness and Safety of Siltuximab for Patients with Castleman's Disease Treated in Italy in a Real-life Context

View source ↗

Summary

An Italian multicenter retrospective observational study is assessing the effectiveness and safety of siltuximab for Castleman's disease in real-life practice i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castleman Disease

Drugs mentioned

• Siltuximab (Sylvant) (siltuximab)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Castleman Disease | Status: RECRUITING